National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve the unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
National Oxygen Ltd has informed BSE that its Board of Directors will meet on Friday, 30 January 2026, to consider and approve the unaudited financial results for the quarter ended 31 December 2025 (Q3 FY26). The company is a Chennai-based manufacturer of liquid and gaseous oxygen, nitrogen, medical oxygen, and dissolved acetylene gas. The trading window for insiders has been closed since 1 January 2026 and will reopen 48 hours after the board meeting. The intimation has been issued under SEBI LODR Regulations 29 and 33.
This is a routine regulatory filing and does not contain any financial data. Investors should watch for the actual Q3 FY26 results on 30 January 2026, which could move the stock depending on performance versus expectations. The closed trading window also signals that insiders are restricted from trading until results are disclosed.